Fidelity Investments, an investment management company, recently released its “Fidelity Growth Strategies Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Fidelity Growth Strategy is a diversified equity strategy aimed at domestic midcap growth stocks. The approach focuses on identifying quality companies that deliver steady above-average growth and can outperform over time. The Fund (Retail Class shares) returned -3.44% in the quarter compared to the benchmark Ru ...

Axon Enterprise, Inc. (NASDAQ:AXON) is one of the stocks Jim Cramer shared his opinion on. A caller asked about Cramer’s thoughts on the stock, and he remarked: You know, I saw the body camera story in Minnesota. First thing I said was like, does Axon have that contract? And I don’t know the answer. I’m going to certainly find out about it. I know that the stock was up because of it, and then reversed. I want you to trim it again, alright? I want you to trim it again because it should have been up today, ...

Core Viewpoint - Baillie Gifford continues to focus on technology and growth sectors, maintaining a global perspective despite a reduction in total assets held to $120 billion, down $15 billion from the previous quarter [1]. Holdings Overview - As of Q4 2025, Baillie Gifford holds a total of 265 companies with assets amounting to $120 billion, reflecting a decrease of $15 billion from Q3 [1]. Top Holdings - The firm remains heavily invested in global technology and consumer giants, with a notable emphasis on Latin American e-commerce platform MercadoLibre, and Nvidia leading the portfolio, indicating confidence in the long-term potential of AI infrastructure [4]. Top Buys - Significant increases in holdings include: - Axon Enterprise (AXON) with an additional investment of $860 million - Medline Inc (MDLN) with $437 million - Rocket Lab (RKLB) with $399 million - Google-A (GOOGL) with $373 million - Duolingo (DUOL) with $357 million - The firm shows strong interest in vertical technology sectors, particularly in safety technology and education [5][6]. Top Sells - The firm has reduced its positions in: - Datadog Inc (DDOG) by $1.01 billion - Cloudflare (NET) by $990 million - Shopify (SHOP) by $680 million - BioNTech SE (BNTX) by $630 million - Meta Platforms (META) by $590 million - This indicates a strategic retreat from cloud computing and vaccine-related companies, likely based on valuation and growth switching logic [7][8]. New Positions - New investments include: - Medline Inc (MDLN) with $437 million - United Therapeutics (UTHR) with $157 million - MongoDB (MDB) with $112 million - BillionToOne (BLLN) with $104 million - Silvergate Capital (SVM) with $35 million - The new positions reflect Baillie Gifford's exploration in emerging fields such as rare disease treatment and databases, showcasing a commitment to long-term tracking in technology and healthcare [9][10].

Axon Enterprise (AXON) is set to release its fourth-quarter 2025 earnings on Feb. 24 amid mounting investor concerns over its lofty valuation. The company, a leader in public safety technology, has seen its stock stumble early in the year, reflecting broader market jitters about high-growth tech firms trading at premium multiples. Despite this, Axon continues to expand its AI capabilities, highlighted by its November agreement to acquire Carbyne for $625 million. This move integrates cloud-native 911 tec ...

Shares of Axon Enterprise (NASDAQ: AXON), the maker of TASER electrical weapons and body cameras, were taking a dive this week, even though there was no major company-specific news out on it. Instead, the sell-off seemed to be part of a broader wipeout in software-as-a-service (SaaS) stocks due to concerns about disruption from AI and lofty valuations in the sector. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join St ...

Core Viewpoint - Axon Enterprise has demonstrated exceptional stock performance over the past decade, consistently delivering positive returns even during broader market downturns, with a significant stock price increase of 3,340% from the end of 2015 to 2024 [2][3]. Company Performance - From 2016 to 2024, Axon generated positive returns in every year, contrasting with the S&P 500, which had two losing years [2]. - In 2025, Axon experienced a 4% decline in stock price, marking its first underperformance against the S&P 500 since 2017, despite being up over 40% at one point during the year [5]. Revenue Growth - Axon has achieved robust revenue growth, with over 30% growth in the last seven quarters and in 14 of the last 15 quarters [6]. - The company raised its full-year revenue guidance for 2025 to $2.74 billion, reflecting a 31% annual growth [7]. Valuation and Market Position - The stock's growth has been constrained by a significant increase in its price-to-sales ratio, which rose from 4 a decade ago to 19 today [7]. - Despite valuation challenges, Axon is well-positioned for future growth due to strategic acquisitions and product innovations [7][8]. Strategic Acquisitions - Axon has made key acquisitions, including Prepared and Carbyne, which have expanded its total addressable market by $5 billion to $159 billion [8]. - The launch of Axon 911, utilizing AI technology for emergency response, is a significant development that enhances the company's service offerings [8]. Technological Innovations - The introduction of a generative AI product called Draft One, which automates police report writing, exemplifies Axon's commitment to leveraging technology to improve efficiency [9]. - Axon is expanding its market for body cameras, achieving its largest sale in 2024 to a package delivery company [10]. Long-term Outlook - The company is viewed as healthy and capable of returning to its previous growth trajectory, with strategic moves indicating a focus on long-term success [12][13].

Scottsdale, Arizona-based Axon Enterprise, Inc. (AXON) is a public safety company that develops and sells both conducted electrical weapons and an integrated suite of hardware and cloud-based software solutions for law enforcement and public safety agencies. Valued at a market cap of $50.2 billion, the company is scheduled to announce its fiscal Q4 earnings for 2025 in the near future. Ahead of this event, analysts expect this defense company to report a loss of $0.20 per share, down 122.5% from a profit ...

Axon Enterprise Inc. (NASDAQ:AXON) is one of the best future stocks to buy for the long term. On January 6, Northcoast analyst Keith Housum upgraded Axon to Buy from Neutral, while setting a $742 price target on the shares. Earlier on December 17, Morgan Stanley analyst Meta Marshall lowered the firm’s price target on Axon to $713 from $760 and kept an Overweight rating on the shares. In a year-ahead outlook, Marshall noted that the AI trade expanded beyond semiconductor stocks in 2025 to include infrastr ...

Core Insights - Axon Enterprise's stock experienced a 4% decline in 2025 after more than doubling in 2024, yet the company maintains strong long-term growth prospects [1] Company Overview - Axon specializes in technology-driven public safety products, including innovative devices and a growing cloud-based platform that integrates hardware and software [2] - The company is widely recognized for its Taser product, having sold over 1 million units, with a goal to reduce police-related deaths by 50% by 2033 [2] Financial Performance - In the third quarter, Axon reported a 31% year-over-year increase in sales, although it faced a small operating loss and a net loss of $2 million due to growth-related expenses [3] - Despite the recent losses, Axon has reported positive net income in years prior to the third quarter [3] Revenue Model - Axon's business model includes long-term contracts and recurring revenue, creating a high barrier to entry for competitors [4] - Annual recurring revenue rose by 41% year-over-year in the third quarter, reaching $1.3 billion, with future contracted bookings totaling $11.4 billion [4] Valuation Metrics - Axon stock has a forward one-year P/E ratio of 61 and a price-to-free-cash-flow ratio of 329, indicating a premium valuation typical for high-growth stocks [6] - The premium valuation is supported by the company's strong performance and long-term opportunities, despite the stock's poor performance in the previous year [6] Investment Considerations - While Axon does not appear to be a bargain at its current price, it may be suitable for long-term investors who could consider a dollar-cost-averaging strategy for better entry points [7]

In the current session, the stock is trading at $628.00, after a 0.22% increase. Over the past month, Axon Enterprise Inc. (NASDAQ:AXON) stock increased by 10.25%, and in the past year, by 9.94%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.Comparing Axon Enterprise P/E Against Its PeersThe P/E ratio is used by long-term shareholders to assess the company's market performance agai ...